We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+30.6%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$43.1B
AUM Growth
+$3.9B
Cap. Flow
+$196M
Cap. Flow %
0.46%
Top 10 Hldgs %
17.24%
Holding
3,508
New
269
Increased
1,735
Reduced
1,181
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 9.57%
2 Healthcare 9.13%
3 Financials 8.63%
4 Industrials 6.92%
5 Communication Services 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FXO icon
501
First Trust Financials AlphaDEX Fund
FXO
$1.14B
$15.3M 0.04%
552,904
+273,754
+98% +$7.61M
TSLA icon
502
Tesla
TSLA
$1.3T
$15.3M 0.04%
822,750
-20,640
-2% -$349K
LYG icon
503
Lloyds Banking Group
LYG
$91.3B
$15.3M 0.04%
4,485,979
+1,257,292
+39% +$4.24M
FLS icon
504
Flowserve
FLS
$10.2B
$15.2M 0.04%
314,297
+77,878
+33% +$3.77M
AL
505
DELISTED
Air Lease Corp
AL
$15.1M 0.04%
390,590
-7,325
-2% -$276K
ADX icon
506
Adams Diversified Equity Fund
ADX
$3.2B
$15.1M 0.04%
1,100,325
+86,459
+9% +$1.16M
UPGD icon
507
Invesco Bloomberg Analyst Rating Improvers ETF
UPGD
$121M
$15.1M 0.04%
376,010
+13,438
+4% +$530K
RWJ icon
508
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$2.1B
$15M 0.03%
679,770
+130,104
+24% +$2.9M
LRCX icon
509
Lam Research
LRCX
$390B
$15M 0.03%
1,166,840
+520,340
+80% +$6.12M
REGN icon
510
Regeneron Pharmaceuticals
REGN
$80.8B
$15M 0.03%
38,633
+7,134
+23% +$2.64M
ZBH icon
511
Zimmer Biomet
ZBH
$18.4B
$14.9M 0.03%
126,050
-10,746
-8% -$1.22M
FLEX icon
512
Flex
FLEX
$44.8B
$14.9M 0.03%
1,173,280
+108,977
+10% +$1.31M
MCK icon
513
McKesson
MCK
$101B
$14.9M 0.03%
100,168
+24,086
+32% +$3.53M
IWP icon
514
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
$14.8M 0.03%
285,732
-4,440
-2% -$227K
ALK icon
515
Alaska Air
ALK
$5.58B
$14.7M 0.03%
159,393
+10,164
+7% +$962K
SDOG icon
516
ALPS Sector Dividend Dogs ETF
SDOG
$1.43B
$14.6M 0.03%
339,212
-137,367
-29% -$5.92M
LSXMK
517
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$14.6M 0.03%
493,174
+39,623
+9% +$1.12M
CI icon
518
Cigna
CI
$74.6B
$14.5M 0.03%
99,122
+4,374
+5% +$645K
VVC
519
DELISTED
Vectren Corporation
VVC
$14.4M 0.03%
246,378
-116,612
-32% -$6.47M
CSX icon
520
CSX Corp
CSX
$93.1B
$14.4M 0.03%
925,593
-148,653
-14% -$2.27M
BSX icon
521
Boston Scientific
BSX
$71.5B
$14.3M 0.03%
576,697
-86,846
-13% -$2.11M
EPAC icon
522
Enerpac Tool Group
EPAC
$1.93B
$14.3M 0.03%
543,522
+44,982
+9% +$1.21M
LEA icon
523
Lear
LEA
$8.18B
$14.3M 0.03%
100,937
+19,989
+25% +$2.84M
BIV icon
524
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
$14.3M 0.03%
170,487
+44,009
+35% +$3.66M
GAM
525
General American Investors Company
GAM
$1.61B
$14.2M 0.03%
425,091
+6,779
+2% +$223K

Similar funds

Raymond James & Associates's Q1 2017 Portfolio in Review

As of Q1 2017, Raymond James & Associates held 3,508 positions worth $43.1B, up 10% from $39.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Raymond James & Associates's Q1 2017 filing shows 269 new, 1,735 increased, 1,181 reduced and 217 closed positions. Its largest new stake was iShares Global REIT ETF: 2,916,742 shares worth $73.9M. The largest sale was TotalEnergies, an estimated $1.85B.

By sector, the portfolio is most concentrated in Technology at 9.6% of assets, up from 9.2% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q1 2017 buy was iShares Global REIT ETF: 2,916,742 shares worth $73.9M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2017, an estimated $997M increase.
  • Raymond James & Associates's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $1.85B.
  • Raymond James & Associates fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $23.6M.
  • Raymond James & Associates's ten largest holdings make up 17% of its $43.1B portfolio in Q1 2017.
  • Raymond James & Associates opened 269 new positions and closed 217 in Q1 2017.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $43.1B.

Based on Raymond James & Associates's 13F filing for Q1 2017, filed 15 May 2017.